• 1
    Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985;139: 10311038.
  • 2
    Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986;315: 8186.
  • 3
    Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden. IV. Epidemiological trends 1959–78. Acta Paediatr Scand 1984;73: 433440.
  • 4
    Stanley FJ, Watson L. The cerebral palsies in Western Australia: trends, 1968 to 1981. Am J Obstet Gynecol 1988;158: 8993.
  • 5
    MacLennan A. A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement. International Cerebral Palsy Task Force. BMJ 1999;319: 10541059.
  • 6
    Eastman NJ, DeLeon M. The etiology of cerebral palsy. Am J Obstet Gynecol 1955;69: 950961.
  • 7
    Nelson KB, Ellenberg JH. Epidemiology of cerebral palsy. Adv Neurol 1978;19: 421435.
  • 8
    Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case–control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995;346: 14491454.
  • 9
    O'Shea TM, Klinepeter KL, Dillard RG. Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol 1998;147: 362369.
  • 10
    Dammann O, Allred EN, Veelken N. Increased risk of spastic diplegia among very low birth weight children after preterm labor or prelabor rupture of membranes. J Pediatr 1998;132: 531535.
  • 11
    Allan WC, Vohr B, Makuch RW, Katz KH, Ment LR. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med 1997;151: 580585.
  • 12
    Cooke RW. Cerebral palsy in very low birthweight infants. Arch Dis Child 1990;65: 201206.
  • 13
    Jacobsson B, Hagberg G, Hagberg B, Ladfors L, Niklasson A. Cerebral palsy in preterm infants:a population based analysis of antenatal risk factors. Am J Obstet Gynecol 2000;182(Suppl):S29.
  • 14
    Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278: 207211.
  • 15
    Wu YW, Colford JM, Jr Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284: 14171424.
  • 16
    Leviton A, Gilles F, Neff R, Yaney P. Multivariate analysis of risk of perinatal telencephalic leucoencephalopathy. Am J Epidemiol 1976;104: 621626.
  • 17
    Gilles FH, Averill DR, Jr Kerr CS. Neonatal endotoxin encephalopathy. Ann Neurol 1977;2: 4956.
  • 18
    Bejar R, Wozniak P, Allard M, et al. Antenatal origin of neurologic damage in newborn infants. I. Preterm infants. Am J Obstet Gynecol 1988;159: 357363.
  • 19
    Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174: 14331440.
  • 20
    Verma U, Tejani N, Klein S, et al. Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. Am J Obstet Gynecol 1997;176: 275281.
  • 21
    Zupan V, Gonzalez P, Lacaze-Masmonteil T, et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 1996;38: 10611067.
  • 22
    Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics 1996;97: 822827.
  • 23
    Alexander JM, Gilstrap LC, Cox SM, McIntire DM, Leveno KJ. Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstet Gynecol 1998;91: 725729.
  • 24
    Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341: 11901196.
  • 25
    Leviton A, Paneth N, Reuss L, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res 1999;46: 566575.
  • 26
    Roland EH, Magee JF, Rodriguez E, Lupton BA, Hill A. Placental abnormalities: insights into pathogenesis of cystic periventricular leukomalacia. Ann Neurol 1996;40: 3213.
  • 27
    Cummins SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr 1993;123: 230237.
  • 28
    Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?. Dev Med Child Neurol 1993;35: 553558.
  • 29
    Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177: 1926.
  • 30
    Martinez E, Figueroa R, Garry D, et al. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Matern Fetal Investig 1998;8: 101107.
  • 31
    Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182: 675681.
  • 32
    Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183: 11241129.
  • 33
    Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177: 797802.
  • 34
    Debillon T, Gras-Leguen C, Verielle V, et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000;47: 736742.
  • 35
    Sharief MK, Thompson EJ. In vivo relationship of tumor necrosis factor-alpha to blood–brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 1992;38: 2733.
  • 36
    Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177: 406411.
  • 37
    Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol 1996;14: 1316.
  • 38
    Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87: 949954.
  • 39
    Tyor WR, Glass JD, Griffin JW, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31: 349360.
  • 40
    Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 1991;58: 331342.